This case presentation discusses chronic renal failure in a 72-year-old female patient. It provides details on the definition, epidemiology, etiology, pathophysiology, staging, symptoms, complications, diagnosis and treatment of chronic kidney disease. It also includes the patient's demographic details, physical examination findings, investigations, treatment plan involving various medications, and monitoring of vital signs over 4 days.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
3. INTRODUCTION
▣ DEFINITION - CHRONIC KIDNEY DISEASE (CKD) REFERS TO AN IRREVERSIBLE
DETERIORATION OR LOSS OF LARGE NUMBERS OF FUNCTIONING NEPHRONS AND
CAUSE LOSS OF THE EXCRETORY, METABOLIC AND ENDOCRINE FUNCTIONS OF THE
KIDNEY
▣ SERIOUS CLINICAL SYMPTOMS USUALLY DO NOT OCCUR UNTIL THE NUMBER OF
FUNCTIONAL NEPHRONS FALLS TO AT LEAST 70 TO75 PERCENT BELOW NORMAL.
4. RECENT DEFINITION
▣ KIDNEY DAMAGE FOR >3MONTHS WITH OR WITH OUT DECREASED GFR MANIFEST BY
EITHER
▣ PATHOLOGICAL ABNORMALITIES IN THE COMPOSITION OF BLOOD URINE OR
ABNORMALITIES IN IMAGING TEST
OR
▣ GFR < 60ML /MIN /1.73M2 FOR> 3MONTHS WITH OR WITHOUT KIDNEY DAMAGE
5. STAGING
THE DIFFERENT STAGES OF CKD FORM A CONTINUUM.
THE STAGES OF CKD ARE CLASSIFIED AS FOLLOWS :
STAGE 1: KIDNEY DAMAGE WITH NORMAL OR INCREASED GFR (>90
ML/MIN/1.73 M 2)
STAGE 2: MILD REDUCTION IN GFR (60-89 ML/MIN/1.73 M 2)
STAGE 3A: MODERATE REDUCTION IN GFR (45-59 ML/MIN/1.73 M 2)
STAGE 3B: MODERATE REDUCTION IN GFR (30-44 ML/MIN/1.73 M 2)
STAGE 4: SEVERE REDUCTION IN GFR (15-29 ML/MIN/1.73 M 2)
STAGE 5: KIDNEY FAILURE (GFR < 15 ML/MIN/1.73 M 2 OR DIALYSIS)
BY ITSELF, MEASUREMENT OF GFR MAY NOT BE SUFFICIENT FOR IDENTIFYING STAGE
1 AND STAGE 2 CKD,
BECAUSE IN THOSE PATIENT'S THE GFR MAY IN FACT BE NORMAL OR BORDERLINE
NORMAL. IN SUCH CASES,
THE PRESENCE OF ONE OR MORE OF THE FOLLOWING MARKERS OF KIDNEY DAMAGE CAN
ESTABLISH THE DIAGNOSIS :
ALBUMINURIA (ALBUMIN EXCRETION > 30 MG/24 HR. OR
ALBUMIN:CREATININE RATIO > 30 MG/G [> 3 MG/MMOL])
URINE SEDIMENT ABNORMALITIES
ELECTROLYTE AND OTHER ABNORMALITIES DUE TO TUBULAR DISORDERS
HISTOLOGIC ABNORMALITIES
STRUCTURAL ABNORMALITIES DETECTED BY IMAGING
HISTORY OF KIDNEY TRANSPLANTATION IN SUCH CASES
6. EPIDEMOLOGY
GLOBALLY, 8% TO 16% OF THE GENERAL POPULATION HAS CKD.
1.9 MILLION PEOPLE ARE UNDERGOING RENAL REPLACEMENT THERAPY.
PREVELANCE OF CKD INCREASES WITH AGE ; 30% IN GREATER THAN 70 YEARS OLD.
DIABETES AND HYPERTENSION ARE TWO IMPORTANT RISK FACTORS FOR CKD.
IN PATIENTS WITH TYPE 2 DIABETES, PREVELANCE OF 27%.
AMONG T1DM; 17% TO 25% OF PATIENTS DEVELOPED DIABETIC CHRONIC KIDNEY DISEASE (DCKD) AFTER 30 YEARS.
7. ETIOLOGY OF CRF
• CAUSES OF CHRONIC KIDNEY DISEASE (CKD) INCLUDE THE FOLLOWING :
• DIABETIC KIDNEY DISEASE
• HYPERTENSION
• VASCULAR DISEASE(ANGINA & MI)
• GLOMERULAR DISEASE(PRIMARY OR SECONDARY)
• TUBULOINTERSTITIAL DISEASE(NEPHRITIS AFFECTING THE INTERSTITIUM OF THE KIDNEYS)
• URINARY TRACT OBSTRUCTION OR DYSFUNCTION
• RECURRENT KIDNEY STONE DISEASE
• CONGENITAL DEFECTS OF THE KIDNEY OR BLADDER
• UNRECOVERED ACUTE KIDNEY INJURY
8. SYMPTOMS
• TIREDNESS
• WEAKNESS
• NOT SLEEPING WELL
• LESS DESIRE TO EAT THAN USUAL
• NAUSEA
• ITCHING
• SHORTNESS OF BREATH
• ALTERED TASTE
• ALTERED MENTAL STATE
9. NDD-CKD VS ESRD
• THE TERM NON DIALYSIS DEPENDENT CKD ALSO ABBREVIATED AS NDD-CKD IS A
DESIGNATION USED TO ENCOMPASSES THE STATUS OF THOSE PERSONS WITH AN
ESTABLISHED CKD WHO DO NOT YET REQUIRE THE LIFE SUPPORTING TREATMENTS FOR
RENAL FAILURE KNOWN AS RENAL REPLACEMENT THERAPY(INCLUDING MAINTENANCE
DIALYSIS OR RENAL TRANSPLANTATION)
• THE CONDITION OF INDIVIDUALS WITH CKD WHO REQUIRE EITHER OF THE 2 TYPES OF
RENAL REPLACEMENT THERAPY(DIALYSIS OR TRANSPLANTATION) IS REFERRED TO AS THE
END STAGE RENAL DISEASE (ESRD)
10.
11.
12.
13. Complications
• ANEMIA: DUE TO LACK OF ERYTHROPOIETIN
• METABOLIC ACIDOSIS (SEVERE): DUE TO LACK OF NH3 PRODUCTION BY KIDNEYS WHICH IS INVOLVED IN ACID-
BASE BUFFER
• HYPERKALEMIA: DUE TO LACK OF EXCRETION
• PERICARDITIS: DUE TO UREMIA
• OSTEODYSTROPHY (OSTEITIS FIBROSA CYSTICA): DUE TO LACK OF 1,25-
DIHYDROXYCHOLECALCIFEROL AND ALSO SECONDARY HYPERPARATHYROIDISM
• FLUID OVERLOAD (ANASARCA): LACK OF EXCRETION AND NA+ RETENTION
• ENCEPHALOPATHY: DUE TO UREMIA
• HYPERTENSION: DUE TO ACTIVATION OF RAAS. HPT IS THE COMMON CAUSE OF DEATH DUE TO
MYOCARDIAL INFARCTION. MAINTAIN BP <130/80
• INFECTIONS: UREMIA PREVENTS DEGRANULATION OF THE NEUTROPHILS AND SO
• MYELOPEROXIDASE CAN’T BE RELEASED TO DESTROY BACTERIA
• BLEEDING TENDENCIES: DUE TO PLATELETS DYSFUNCTION FROM EFFECTS OF UREMIA
14. DIAGNOSIS
▣ BLOOD
▣ ↑ CREATININE AND BUN
▣ ELECTROLYTES: HYPERKALAEMIA, HYPERPHOSPHATEMIA, HYPOCALCAEMIA
▣ MONITOR BLOOD PH FOR METABOLIC ACIDOSIS
▣ ↓ CALCITRIOL LEVELS
▣ ↑ PARATHYROID HORMONE (PTH)
▣ ULTRASOUND: SHRUNKEN KIDNEYS AND FIBROTIC PARENCHYMA
▣ RENAL BIOPSY: SOMETIMES INDICATED TO DETERMINE THE UNDERLYING CAUSE
16. TREATMENT
• ALTHOUGH CHRONIC KIDNEY DISEASE CANNOT BE CURED , IT IS POSSIBLE TO SLOW THE DAMAGE TO THE
KIDNEY IN MOST PATIENTS. DOCTOR MAY RECOMMEND ANY OF THE FOLLOWING:
• CONTROLLING PROTEIN IN THE URINE BY RESTRICTING THE AMOUNT OF PROTEIN IN THE DIET OR
MEDICATION.
• TAKING ACE INHIBITORS OR ANGIOTENSIN II RECEPTOR ANTAGONISTS TO SLOW THE PROGRESSION TO
CHRONIC RENAL FAILURE.
• REDUCING THE USE OF AND THE DOSAGES OF DRUGS THAT MAY BE TOXIC TO THE KIDNEYS.
• MANAGING THE COMPLICATIONS OF THE CHRONIC RENAL DISEASE SUCH AS FLUID OVERLOAD HIGH BLOOD
PHOSPHATE OR POTASSIUM LEVELS , LOW BLOOD LEVEL OF CALCIUM AND ANAEMIA
17. Non-pharmacological treatment
• ADMIT PATIENT ESPECIALLY IN STAGE OF EXACERBATION
• DIET: RESTRICT DIETARY PROTEIN TO< 40 G/DAY, RESTRICT NA+, K+, PO4-
• INTAKE, AVOID POTASSIUM CONTAINING FOODS E.G. BANANA
• WATER AND ELECTROLYTE BALANCE:
i. DAILY FLUID INTAKE = PREVIOUS DAY’S URINE OUTPUT + 600 ML (FOR INSENSIBLE LOSSES)
ii. STRICT FLUID INPUT AND OUTPUT CHART
• DAILY WEIGHING
• GENERAL HEALTH ADVICE E.G. SMOKING CESSATION
• • AVOID NEPHROTOXINS E.G. NSAIDS , HERBAL MEDICATION
18. PRECAUTIONS
• LOWERING HIGH BLOOD PRESSURE
• CONTROLLING BLOOD SUGAR AND LIPID LEVELS
• STAYING HYDRATED
• CONTROLLING SALT IN DIET
• QUITTING SMOKING
• UNDERGOING DIALYSIS A MEDICAL PROCESS THAT CLEANS BLOOD
• HAVING A KIDNEY TRANSPLANT
• COUNSELLING FOR YOU AND YOUR FAMILY ABOUT DIALYSIS AND/OR TRANSPLANT OPTIONS.
19. PREVENTION
• TO HELP REDUCE YOUR CHANCE OF CHRONIC DISEASE OF CHRONIC KIDNEY FAILURE TAKE THE FOLLOWING
STEPS:
1. GET A PHYSICAL EXAM EVERY YEAR THAT INCLUDES A URINE TEST TO MONITOR YOUR KIDNEY HEALTH
2. DO NOT SMOKE
3. MAINTAIN A HEALTHY WEIGHT.
4. DRINK WATER AND OTHER FLUIDS TO STAY HYDRATED.
5. PEOPLE WHO HAVE DIABETES ,PREVIOUSLY KNOWN KIDNEY DISEASE HIGH BLOOD PRESSURE ARE OVER
THE AGE OF 60 SHOULD BE SCREENED REGULARLY FOR KIDNEY DISEASE
6. PEOPLE WITH A FAMILY HISTORY OF KIDNEY DISEASE SHOULD ALSO BE SCREENED REGULARLY.
20. DISTINGUISHING ACUTE FROM CHRONIC RENAL IMPAIRMENT
• COMPARING ANY PREVIOUS MEASUREMENTS OF SERUM CREATININE WITH THE PATIENTS CURRENT BIOCHEMISTRY. PRE-
EXISTING CHRONIC RENAL IMPAIRMENTS CAN BE EXCLUDED IF A RELATIVELY RECENT PREVIOUS MEASUREMENT OF RENAL
FUNCTION WAS NORMAL.
• A HISTORY OF SEVERE MONTHS VAGUE ILL HEALTH NOCTURIA OR PRURITUS AND FINDINGS OF SKIN PIGMENTATION
ANAEMIA LONG STANDING HYPERTENSION OR NEUROTHERAPY SUGGEST A MORE CHRONIC DISEASE.
• RENAL ULTRASONOGRAPHY TO DETERMINE SIZE AND ECHOGENICITY OF THE KIDNEYS. IT IS NOTE WORTHY THAT RENAL SIZE
IS NORMAL IN MOST PATIENTS WITH ARF.
• ANAEMIA IS A MAJOR FEATURE OF CRF , BUT IT MAY OCCUR EARLY IN THE COURSE OF MANY DISEASE THAT CAUSE ARF.
• BONE DISEASE – EVIDENCE OF LONGSTANDING RENAL BONE DISEASE (EX: RADIOLOGICAL EVIDENCE OF
HYPERPARATHYROIDISM , GREATLY ELEVATED PARATHYROID HORMONE(PTH) LEVELS IS A DIAGNOSTIC OF CRF, BUT
HYPERCALCEMIA AND HYPERPHOSPHATEMIA MAY OCCUR IN BOTH ARF AND CRF.
21. DEMOGRAPHIC DETAILS
• NAME : SUJATHA STATUS : MARRIED
• AGE : 72 YEARS IP.NO : IP19019018
• SEX : FEMALE REG.NO : 202778191
• HEIGHT : 5.4 FEET WEIGHT : 45KG
• PLACE : GUNTUR DOA : 21/02/2021
• RELIGION : HINDU DOD : 26/02/2021
• DEPARATMENT : UROLOGY
• ECONOMIC BACKGROUND : POOR
22. SOAP NOTES
SOAP ANALYSIS :
A 72 YEARS OLD FEMALE PATIENT OF 45 KG’S WEIGHT, 5.4 FEET HEIGHT OF HINDU RELIGION WITH POOR ECONOMIC
BACKGROUND FROM GUNTUR HAVE ADMITTED IN E-WARD.
• SUBJECTIVE DATA :- LACK OF APPETITE, FEVER FOR 2 DAYS,
URINE CONTINUOUS FOR 10 DAYS.
• OBJECTIVE DATA :- ULTRASONOGRAPHY FOR ABDOMEN. SERUM CHLORIDE - 111MMOL/L.
SERUM BILIRUBIN - 2.5 MG/DL.
SERUM INDIRECT BILIRUBIN - 2.2 MG/DL. HAEMOGLOBIN - 9.5GM/DL.
• ASSESSMENT :- BASED ON SUBJECTIVE DATA (URINE CONTINUOUS FEVER) AND LABORATORY DATA OBTAINED THE PATIENT IS
ASSESSED TO BE SUFFERING FROM RENAL FAILURE.
• FINAL DIAGNOSIS :- CHRONIC RENAL DISEASE.
24. ULTRASONOGRAPHY OF ABDOMEN
• GRADE - 1 BILATERAL CHRONIC MEDICAL RENAL DISEASE.
• LARGE PATCH OF CONSOLIDATION AT LOWER LOBE OF RIGHT LUNG.
• ADVISED TEST :- SERUM PROTEIN - 5.5G/DL. PCV - 32%.
• CARDIOLOGY REPORT : SCLEROTIC AORTIC VALVE, NO AC/NO AR, NORMAL CHAMBERS.
• GRADE - 1 DIASTOLIC DYSFUNCTION.
26. PLAN FOR TREATMENT
GOALS OF TREATMENT :-
• TO REDUCE BODY TEMPERATURE.
• TO REDUCE LACK OF APPETITE.
• TO REDUCE URINE CONTINUOUS.
• TO IMPROVE PATIENT CONDITION.
27. MEDICATION:
SL.NO BRAND NAME GENERIC NAME DOSE FREQUENCY ROA DAYS
1 INJ.PANTOP PANTORAZOLE 40mg BD IV 4
2 INJ.ZOFER ONDANSETRON 2mg BD IV 4
3 INJ.TAZACT PIPERACILLIN+
TAZOBACTUM
2.25mg BD IV 4
4 TAB. ZITHROMAX AZITHROMYCIN 250mg BD ORAL 4
5 NEB.DUOLIN
BUDECORT
salbutamol+
ipratropium+
bromide+
budesonide
1.25mg
0.5 mg
TID INHALATION 4
6 TAB.LEVOCET LEVOCETRIZINE 5mg BD ORAL 4
28. TREATMENT GIVEN
1. INJ. PANTOP - 40 MG - BD - IV
GENERIC NAME :- PANTOPRAZOLE.
PHARMACOLOGICAL CLASS :- PROTON PUMP INHIBITOR.
USES :- PREVENTS EXCESS ACID PRODUCTION IN STOMACH.
MOA :- IT WORKS BY INTERFERING WITH THE FINAL STEP OF ACID RELEASE IN THE STOMACH.
INDICATION :- TO TREAT STOMACH ULCERS.
SIDE EFFECTS :- HEADACHE, ALTERED SENSE OF TASTE, RUNNY NOSE AND COUGH.
ADR’S :- SKIN RASH, ANOREXIA, INJECTION SITE THROMBOPHLEBITIS.
CI :- ALLERGY
PREGNANCY CATEGORY :- B.
29. 2. INJ.ZOFER-40MG-BD-IV
GENERIC NAME :- ONDANSETRON.
PHARMACOLOGICAL CLASS :- SELECTIVE 5 - HT3 RECEPTOR.
USES :- TREAT NAUSEA, VOMITING.
MOA :- IT BLOCKS THE ACTION OF SEROTONIN IN THE BODY THAT CAN TRIGGER NAUSEA AND VOMITING'S.
INDICATION :- TO TREAT GASTRO - OESOPHAGEAL REFLEX DISORDERS.
SIDE EFFECTS :- HEADACHE, CONSTIPATION, FATIGUE, FEVER.
ADR’S :- INCREASED LIVER ENZYME LEVELS.
CI :- ALLERGY, APOMORPHINE.
DI :- AMITRIPTYLINE LINE, CARBAMAZEPINE, PHENYTOIN.
PREGNANCY CATEGORY :- A.
30. 3. INJ. TAZACT - 2.2 MG - BD - IV
GENERIC NAME :- PIPERACILLIN (400MG) + TAZOBACTAM (500MG).
PHARMACOLOGICAL CLASS :- BETA-LACTAMASE INHIBITOR.
USES :- BACTERIAL INFECTIONS, URINARY TRACT INFECTIONS, MICROBIAL INFECTIONS.
MOA :- PIPERACILLIN - IT WORKS BY INTERFERING WITH CERTAIN PROCESSES THAT HELP BACTERIA.
TAZOBACTUM - INHIBITS CHEMICALS PRODUCED BY BACTERIA.
INDICATION :- ANTIBACTERIAL AGENT.
SIDE EFFECTS :- DIARRHOEA, FEVER, NAUSEA, VOMITINGS.
ADR’S :- RASH, ITCHING OF SKIN.
CI :- ALLERGY.
DI :- LIVE CHOLERA VACCINE, OXYTETRACYCLINE, PROBENECID.
PREGNANCY CATEGORY : B
31. 4.
• TAB. ZITHROMAX- 250MG - BD - ORAL
GENERIC NAME :- AZITHROMYCIN.
PHARMACOLOGICAL CLASS :- MACROLIDE ANTIBIOTIC.
USES :- PNEUMONIA, NOSE AND THROAT INFECTIONS, SINUS, SKIN INFECTIONS.
MOA :- PIPERACILLIN - AZITHROMYCIN PREVENT BACTERIA FROM GROWING BY INTERFERING WITH THEIR
PROTEIN SYNTHESIS. IT BINDS TO THE 50S SUBUNIT OF THE BACTERIAL RIBOSOME, THUS INHIBITING
TRANSLATION OF MRNA.
INDICATION :- TO TREAT BACTERIAL INFECTIONS.
SIDE EFFECTS :- DIARRHOEA, FEVER, ABDOMEN PAIN, VOMITINGS. ADR’S :- DRY OR SCALY SKIN, ACID OR
SOUR STOMACH.
CI :- HYPERSENSITIVITY, LIVER DAMAGE.
DI :- ATORVASTATIN, AMIODARONE, DIGOXIN.
PREGNANCY CATEGORY :- B.
32. 5. TAB. LEVOCET - 5MG - BD - ORAL
GENERIC NAME :- LEVOCETIRIZINE.
PHARMACOLOGICAL CLASS :- ANTIHISTAMINE.
USES :- RUNNY NOSE, SNEEZING, REDNESS, ITCHING, TEARING OF THE EYES.
MOA :- IT WORKS BY BLOCKING THE ACTION OF A NATURAL SUBSTANCE PRODUCED BY BODY CALLED
HISTAMINE.
INDICATION :- TREAT ALLERGY SYMPTOMS SUCH AS WATERY EYES, RUNNING NOSE.
SIDE EFFECTS :- DIARRHOEA, SLEEPINESS, HEADACHE.
ADR’S :- DIFFICULTY IN PASSING URINE.
CI :- ALLERGY, KIDNEY DISEASE.
DI :- ALPRAZOLAM, CLOBAZAM, CODEINE.
PREGNANCY CATEGORY :- B.
33. 6.NEB. DUOLIN AND BUDECORT – 1.25MG/0.5MG - TID – INHALATION.
GENERIC NAME :- SALBUTAMOL + IPRATROPIUM/BROMIDE + BUDESONIDE.
PHARMACOLOGICAL CLASS :- ANTICHOLINERGIC, CORTICOSTEROID.
USES :- AIRWAY NARROWING, COPD.
MOA :- IT CAUSES BRONCHODILATION. IT WORKS BY RELAXING AND OPENING THE BLOCKED AIR PASSAGES.
INDICATION :- BRONCHODILATION, CONTROL OF WHEEZING.
SIDE EFFECTS :- SNEEZING, COUGH, VIRAL INFECTIONS.
ADR’S :- HEADACHE, TACHYCARDIA TREMOR.
CI :- HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY.
DI :- AMINOPENCILLINS, DIGOXIN22.
PREGNANCY CATEGORY :- B.
34. MONITORING PARAMETERS
• DISEASE SPECIFIC - MONITORING FEVER, URINE PASSAGE. MONITORING RENAL FUNCTION TESTS.
• DRUG SPECIFIC - MONITORING LIVER ENZYME LEVELS. MONITORING ADVERSE DRUG REACTIONS.
ABOUT DRUGS
• TAB. PANTOP SHOULD BE TAKEN WITH EMPTY STOMACH (ATLEAST HALF AN HOUR BEFORE FOOD).
• AZITHROMYCIN USUALLY TAKEN BY MOUTH WITH A GLASS OF WATER ONCE DAILY WITH OR
WITHOUT FOOD.
• LEVOCET SHOULD BE TAKEN WITH OR WITHOUT FOOD.
PATIENT COUNSELLING
• EAT A LOW PROTEIN DIET, LIMITING SALT, POTASSIUM, PHOSPHOROUS.
• AVOID FAST FOODS, FROZEN DINNERS, CANNED FOODS THAT ARE HIGHER IN SODIUM.
• USE OF SPICES, HERBS AND SODIUM FREE SEASONING IN PLAN OF SALT .
• AEROBIC EXERCISE.
• DECREASING MORE SALT INTAKE.
35. DIET FOR CKD PATIENTS
• BREAK FAST - 1.5 SERVING OF CEREAL + A GLASS OF MILK.
• MORNING SNACK - 1 BOWL OF FRUITS (PINE APPLE, STRAW BERRIES).
• LUNCH - A GOOD COMBINATION OF STARCH + PROTEINS AND FATS.
• AFTERNOON - 1 CORN BREAD + BEEF PATTY.
• DINNER - YEAST ROLL STEAMED CHICKEN + SQUASH + MARGARINE.
• PROTEIN RESTRICTION TO 0.6 - 0.8GM/KG/DAY MAY RETARD CKD PROGRESSION
• PHOSPHORUS RESTRICTION - PHOSPHOROUS LEVEL SHOULD BE KEPT IN THE NORMAL RANGE (<4.5MG/DL)
PREDIALYSIS.
• SALT AND WATER RESTRICTION.
• DISCHARGE MEDICATION
• TAB. PANTOP - 40MG - OD - ORAL - 7 DAYS.
TAB. ZITHROMAX- 250MG - OD - ORAL - 7 DAYS.
• TAB. LEVOCET - 5MG - OD - ORAL - 7 DAYS.